Lester Iii Rushin
Examiner (ID: 4348, Phone: (313)446-4905 , Office: P/3651 )
Most Active Art Unit | 3651 |
Art Unit(s) | 3651 |
Total Applications | 787 |
Issued Applications | 662 |
Pending Applications | 45 |
Abandoned Applications | 80 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16390949
[patent_doc_number] => 20200331890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/866778
[patent_app_country] => US
[patent_app_date] => 2020-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866778 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | May 4, 2020 | Issued |
Array
(
[id] => 17603993
[patent_doc_number] => 11332464
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Inhibitors of lysine gingipain
[patent_app_type] => utility
[patent_app_number] => 16/866022
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 27862
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866022 | Inhibitors of lysine gingipain | May 3, 2020 | Issued |
Array
(
[id] => 16222643
[patent_doc_number] => 20200247759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR PRODUCING 5-HYDROXY-1H-IMIDAZOLE-4 CARBOXAMIDE 3/4 HYDRATE
[patent_app_type] => utility
[patent_app_number] => 16/858089
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858089 | Method for producing 5-hydroxy-1H-imidazole-4 carboxamide 3/4 hydrate | Apr 23, 2020 | Issued |
Array
(
[id] => 16222643
[patent_doc_number] => 20200247759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR PRODUCING 5-HYDROXY-1H-IMIDAZOLE-4 CARBOXAMIDE 3/4 HYDRATE
[patent_app_type] => utility
[patent_app_number] => 16/858089
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858089 | Method for producing 5-hydroxy-1H-imidazole-4 carboxamide 3/4 hydrate | Apr 23, 2020 | Issued |
Array
(
[id] => 16222643
[patent_doc_number] => 20200247759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR PRODUCING 5-HYDROXY-1H-IMIDAZOLE-4 CARBOXAMIDE 3/4 HYDRATE
[patent_app_type] => utility
[patent_app_number] => 16/858089
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858089 | Method for producing 5-hydroxy-1H-imidazole-4 carboxamide 3/4 hydrate | Apr 23, 2020 | Issued |
Array
(
[id] => 16222643
[patent_doc_number] => 20200247759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR PRODUCING 5-HYDROXY-1H-IMIDAZOLE-4 CARBOXAMIDE 3/4 HYDRATE
[patent_app_type] => utility
[patent_app_number] => 16/858089
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858089
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858089 | Method for producing 5-hydroxy-1H-imidazole-4 carboxamide 3/4 hydrate | Apr 23, 2020 | Issued |
Array
(
[id] => 17134792
[patent_doc_number] => 11136338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Fused thiazolopyrimidine derivatives as MNKs inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/855701
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38928
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/855701 | Fused thiazolopyrimidine derivatives as MNKs inhibitors | Apr 21, 2020 | Issued |
Array
(
[id] => 16612069
[patent_doc_number] => 20210030722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => 1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
[patent_app_type] => utility
[patent_app_number] => 16/849610
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849610 | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | Apr 14, 2020 | Issued |
Array
(
[id] => 17193087
[patent_doc_number] => 11161827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C--H amination
[patent_app_type] => utility
[patent_app_number] => 16/840879
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 29
[patent_no_of_words] => 34153
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840879 | Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C--H amination | Apr 5, 2020 | Issued |
Array
(
[id] => 16519449
[patent_doc_number] => 10870658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Aldose reductase inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/835876
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14365
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835876 | Aldose reductase inhibitors and methods of use thereof | Mar 30, 2020 | Issued |
Array
(
[id] => 18134735
[patent_doc_number] => 11560388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Anthelmintic aza-benzothiophene and aza-benzofuran compounds
[patent_app_type] => utility
[patent_app_number] => 16/823138
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48557
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 614
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823138
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823138 | Anthelmintic aza-benzothiophene and aza-benzofuran compounds | Mar 17, 2020 | Issued |
Array
(
[id] => 16735570
[patent_doc_number] => 10961205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => 1,2,4-oxadiazole derivatives as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/806872
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7787
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806872
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806872 | 1,2,4-oxadiazole derivatives as immunomodulators | Mar 1, 2020 | Issued |
Array
(
[id] => 16328330
[patent_doc_number] => 20200299296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => ANALOGS OF 3-AMINO-4-(PROPAN-2-YLIDENE)CYCLOPENTANE-1-CARBOXYLIC ACID AND USES THEREOF FOR TREATING DISEASES AND DISORDERS ASSOCIATED WITH ORNITHINE AMINOTRANSFERASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/800753
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16800753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/800753 | Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity | Feb 24, 2020 | Issued |
Array
(
[id] => 16268745
[patent_doc_number] => 20200270232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/799765
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/799765 | INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY | Feb 23, 2020 | Abandoned |
Array
(
[id] => 16008921
[patent_doc_number] => 20200179303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 16/791940
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791940 | USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY | Feb 13, 2020 | Abandoned |
Array
(
[id] => 16460693
[patent_doc_number] => 10844026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Prodrugs of riluzole and their method of use
[patent_app_type] => utility
[patent_app_number] => 16/748354
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16119
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748354
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748354 | Prodrugs of riluzole and their method of use | Jan 20, 2020 | Issued |
Array
(
[id] => 18444492
[patent_doc_number] => 11680050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/748303
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 53
[patent_no_of_words] => 10776
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748303 | Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof | Jan 20, 2020 | Issued |
Array
(
[id] => 16590492
[patent_doc_number] => 10899742
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-01-26
[patent_title] => Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
[patent_app_type] => utility
[patent_app_number] => 16/744414
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 249
[patent_figures_cnt] => 11
[patent_no_of_words] => 67715
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744414 | Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders | Jan 15, 2020 | Issued |
Array
(
[id] => 15828353
[patent_doc_number] => 20200129458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS
[patent_app_type] => utility
[patent_app_number] => 16/728836
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16728836
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/728836 | COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS | Dec 26, 2019 | Abandoned |
Array
(
[id] => 17904261
[patent_doc_number] => 11458092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Composition with enhanced passenger molecule loading
[patent_app_type] => utility
[patent_app_number] => 16/705468
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8995
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16705468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/705468 | Composition with enhanced passenger molecule loading | Dec 5, 2019 | Issued |